Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients
Condition(s):Glioblastoma Multiforme; MeningiomaLast Updated:March 27, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Glioblastoma Multiforme; MeningiomaLast Updated:March 27, 2024Active, not recruiting
Condition(s):Glioblastoma; GliomaLast Updated:June 7, 2018Unknown status
Condition(s):High Grade Glioma; Diffuse Intrinsic Pontine Glioma; Anaplastic Astrocytoma; Glioblastoma; Glioblastoma Multiforme; Diffuse Midline Glioma, H3 K27M-Mutant; Metastatic Brain Tumor; WHO Grade III Glioma; WHO Grade IV GliomaLast Updated:November 22, 2023Not yet recruiting
Condition(s):Breast Cancer FemaleLast Updated:May 15, 2023Recruiting
Condition(s):CNS Embryonal Tumor, Not Otherwise Specified; Malignant Glioma; Recurrent Atypical Teratoid/Rhabdoid Tumor; Recurrent Childhood Ependymoma; Recurrent Diffuse Intrinsic Pontine Glioma; Recurrent Medulloblastoma; Refractory Diffuse Intrinsic Pontine GliomaLast Updated:August 27, 2021Completed
Condition(s):Breast CancerLast Updated:February 8, 2024Available
Condition(s):Breast CancerLast Updated:October 24, 2023Completed
Condition(s):Breast CancerLast Updated:December 28, 2023Active, not recruiting
Condition(s):Breast CancerLast Updated:January 9, 2023Recruiting
Condition(s):Metastatic Hormone-Receptor-Positive (HR+) Breast Cancer; HER2-Negative Breast Cancer; Metastatic Epithelial Ovarian CancerLast Updated:March 31, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.